Sequenom, Inc. (SQNM) Posts Q2 Loss of 27c/Share; Issues MaterniT21 PLUS Update

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/13/2026

Buy Sequenom (SQNM) Aggressively, Issues 'Not End of World' - Wedbush

July 25, 2013 9:43 AM EDT

Wedbush today maintained an Outperform rating on Sequenom (NASDAQ: SQNM) with a price target of $5.00. Shares tumbled as a result of disappointing earnings on Wednesday. Along with many other companies in the diagnostics industry, Sequenom experienced delays in receipt of payments as a result of... More

Ladenburg Thalmann Downgrades Sequenom (SQNM) to Neutral

July 25, 2013 8:24 AM EDT

Ladenburg Thalmann downgraded Sequenom (NASDAQ: SQNM) from Buy to Neutral.

For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.

Shares of Sequenom closed at $4.69 yesterday, with a 52 week range of $2.65-$5.36.... More

William Blair Downgrades Sequenom (SQNM) to Market Perform

July 25, 2013 7:17 AM EDT

William Blair downgraded Sequenom (NASDAQ: SQNM) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.

Shares of Sequenom closed at $4.69 yesterday, with a 52 week range of $2.65-$5.36.... More

Lazard Capital Downgrades Sequenom (SQNM) to Neutral

July 25, 2013 7:16 AM EDT

Lazard Capital downgraded Sequenom (NASDAQ: SQNM) from Buy to Neutral.

For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.

Shares of Sequenom closed at $4.69 yesterday, with a 52 week range of $2.65-$5.36.... More

Sequenom, Inc. (SQNM) trading halted with news pending.

July 24, 2013 4:01 PM EDT